Marine Bioproducts CRC (MBCRC) is delighted to announce the appointment of our new Chief Commercial Officer, Dr Anthony Dyer.
Anthony has a PhD in marine biotechnology and a lifelong passion for marine issues. He also has a long and productive history in contributing to the CRC program including establishing several spin out organisations, new technologies and research translation.
He is currently the CEO and Executive Director of Wounds Innovation Ltd, a highly successful spinout company of the Wound Management and Innovation CRC, and proudly accepted the Collaborative Research Australia (CRA) Award for Impact in 2023.
Anthony brings a strong history of developing and implementing IP and commercialisation strategies, along with an extensive network of relationships across research and industry partners.
We look forward to welcoming Anthony to MBCRC on 1 February 2025.